FAQS

BELLUS Health’s headquarters are located at 275 Armand-Frappier Blvd. Laval, Quebec, Canada H7V 4A7. The main office phone number is (450) 680-4500.

US Office: 2751 Centerville Road, Suite 100, Wilmington, DE 19808

BELLUS Health’s common shares are traded on the NASDAQ Global Market under the symbol BLU and the Toronto Stock Exchange under the symbol BLU.

BELLUS Health’s fiscal year ends on December 31.

BELLUS Health’s independent auditors are:

KPMG LLP
600 de Maisonneuve Blvd West
Suite 1500, Tour KPMG
Montreal, Quebec H3A 0A3
Tel. 514-840-2100
Fax. 514-840-2187

BELLUS Health common shares can be purchased through a stockbroker of your choice. BELLUS Health does not have a direct stock purchase plan.

The CUSIP number for BELLUS Health’s common shares is 07987C204.

BELLUS Health does not expect to declare or pay any cash or other dividends on its common shares, as it intends to reinvest cash flow generated by operations in its business.

BELLUS Health’s transfer agent is:

Computershare Investor Services Inc.
100 University Avenue
9th Floor, North Tower
Toronto, Ontario M5J 2Y1
Telephone number:
1-514-982-7555 (direct line)
1-800-564-6253 (Canada and US)

If you have misplaced your BELLUS Health common share certificates, please contact BELLUS Health’s transfer agent, Computershare Investor Services Inc. (refer to contact information above).

There may be a fee involved for replacing lost common share certificates.